PERSPECTA

News from every angle

← Back to headlines

Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths

Novartis has suspended multiple clinical studies of its experimental CAR-T cell therapies for autoimmune diseases after three patients died during treatment. The company is conducting a thorough safety review before determining whether to resume or modify the trials.

1 Sept, 05:28 — 1 Sept, 05:28
PostShare

Sources

Showing 1 of 4 sources
seeking-alphaMixed3h ago

Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ

Read full article →

Coverage Timeline

First report: wsj · 1 Sept, 04:14Full coverage: 4 · 1hWindow: 1h
Left-leaningCenterRight-leaning
wsj1 Sept, 04:14First to report

Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ

Reuters1 Sept, 04:38

Novartis pauses autoimmune cell therapy studies after deaths, WSJ reports - Reuters

hotnews1 Sept, 05:16

Novartis oprește mai multe studii clinice după decese în rândul pacienților

seeking-alpha1 Sept, 05:28Latest update

Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ

Related Stories

Lionel Richie Hospitalized in Intensive Care After Concert Illness

56m ago

Lionel Richie Hospitalized in ICU Following St. Louis Concert

2h ago

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

14h ago

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases

16h ago